Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
In general three drugs are better than two are better than one
| The first 150 words of the full text of this article appear below. |
In this issue Rachel Jordan and colleagues have provided a meta-analysis of published controlled clinical trials, which provide significant information relevant to the initial treatment of established HIV infection in adults and adolescents (p 757).1 Their analyses are based on a large number of well conducted clinical trials. The data largely confirm earlier observations, often from relatively small studies, which have shown that dual nucleoside antiretroviral regimens are significantly more effective than single nucleoside therapy, and that three drug antiretroviral regimens are significantly better than two drug regimens for initial therapy of HIV infection.
The conclusions of the meta-analysis are entirely consistent with
current consensus recommendations that initial therapy for established
HIV infection in adults and adolescents should include a combination of
three potent antiretroviral drugs.2-4 Since the major
biological factor in failure of antiretroviral therapy is the
development of viral mutations which confer resistance to specific
antiretroviral agents,